MN 553 Unit 9 Quiz | Questions with Answers 2023/2024 | Latest Graded A+

MN 553 Unit 9 Quiz | Questions with Answers 2023/2024 | Latest Graded A+. Pharmacogenetic testing is required by the U.S. Food and Drug Administration prior to prescribing: Question options: Erythromycin Digoxin Cetuximab Rifampin Question 6 1 / 1 point Carbamazepine has a Black Box Warning recommending testing for the HLA-B*1502 allele in patients with Asian ancestry prior to starting therapy due to: Question options: Decreased effectiveness of carbamazepine in treating seizures in Asian patients with the HLA-B*1502 allele Increased risk for drug interactions in Asian patients with the HLA-B*1502 allele Increased risk for Stevens-Johnson syndrome in Asian patients with HLA-B*1502 Allele Patients who have the HLA-B*1502 allele being more likely to have a resistance to carbamazepine Question 7 1 / 1 point A genetic variation in how the metabolite of the cancer drug irinotecan SN-38 is inactivated by the body may lead to: Question options: Decreased effectiveness of irinotecan in the treatment of cancer Increased adverse drug reactions, such as neutropenia Delayed metabolism of the prodrug irinotecan into the active metabolite SN-38 Increased concerns for irinotecan being carcinogenic Question 8 1 / 1 point A good history of herb and supplement use is critical before prescribing because approximately ____ % of patients in the United States are using herbal products